Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israël, Tel Aviv
Ofer Merimsky
41 années d'expérience
accréditations :
La clinique est certifiée :
| Israël | Turquie | Espagne | |
| Élimination du cancer du foie | de $22,000 | de $10,800 | de $35,000 |
| Thérapie par faisceau de protons | de $48,000 | de $70,000 | de $25,790 |
| NanoCouteau | de $18,500 | de $9,500 | de $12,000 |
| CyberCouteau | de $17,500 | de $4,750 | de $30,000 |
| Chimioembolisation du foie | de $14,800 | de $7,500 | de $12,000 |
Le professeur Merimsky dirige l'unité des sarcomes au centre médical Sourasky, apportant une expertise approfondie dans le traitement du cancer du foie avec plus de 30 ans d'expérience.
Le Dr Pelles Sharon se spécialise dans les traitements de pointe du cancer du foie au centre médical Sourasky, notamment la chimiothérapie et les thérapies ciblées. Elle contribue activement à la recherche oncologique, garantissant des soins aux patients fondés sur des données probantes.
Le Pr Arber se spécialise dans la prévention et le diagnostic des cancers gastro-intestinaux, et pas seulement dans leur traitement. Il dirige le centre de prévention du cancer au centre médical Sourasky.
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.